Monday, November 9, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 493 (TSXV: $KHRN.V) (NYSE: $ACB) (TSX: $ACB.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSX: $RIV.TO)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 493 (TSXV: $KHRN.V) (NYSE: $ACB) (TSX: $ACB.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSX: $RIV.TO)

 


Delta, Kelowna, BC, November 9, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/110920-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/11091KHRN-ACB-WEED-CGC-RIV.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public announcements.

 

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters, to increase the size of its previously announced "bought deal" financing from $10,012,500 to $12,600,000. Pursuant to the amended terms, the Underwriters have agreed to purchase 28,000,000 units of the Company on a "bought deal" basis, pursuant to a short form prospectus at a price per Unit of $0.45 for gross proceeds of $12,600,000.

 

The Company has also granted the Underwriters an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, the Company will receive an additional $1,890,000 in gross proceeds for total aggregate gross proceeds of $14,490,000.

 

Each Unit will be comprised of one common share in the capital of the Company, and one warrant. Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.75, for a period ending five years from the closing of the Offering.

 

The Company intends to use the net proceeds of the Offering to expand the Company's operating capacity and for working capital requirements and other general corporate purposes.

 

In connection with the Offering the Company has agreed to pay the Underwriters a cash commission equal to 6.0% of the gross proceeds raised from the Offering (including on any exercise of the Over-Allotment Option), and non-transferable compensation options equal to 6.0% of the Units sold under the Offering. Each compensation option will be exercisable at the Issue Price to acquire one Unit for a period of 24 months following the closing of the Offering.

 

The closing date of the Offering is scheduled to be on or about November 26, 2020 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities.

 

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the first quarter of fiscal 2021 ended September 30, 2020.

 

"We continue to take the necessary steps to execute our plan and transform our business to achieve sustainable profitability, and ultimately positive cash flow," stated Miguel Martin, Chief Executive Officer of Aurora Cannabis. "Our Q1 2021 results are transitional but do highlight successes across a number of diverse profit pools. We remain the leader by revenue in the high-margin Canadian medical market, our international medical business experienced more than 40% net revenue growth this quarter, and our CBD brand Reliva is #1 ranked by Nielsen in the U.S. CBD sector."

 

"While we are not satisfied with our past performance in the growing Canadian consumer business, we have a sense of urgency in the execution of our tactical plan to grow profitable market share. Our efforts are directed at delivering the highest quality products, refocusing on our leading premium and ultra-premium brands, better allocating our sales and marketing spend, and executing key account partnerships at both the province and retail levels."

 

"We have also taken action to improve our liquidity and strengthen our balance sheet. It was a responsible decision to raise capital using our ATM in today's environment and the cash is expected to ensure we have the runway needed to compete with our peers. Cannabis companies are being evaluated on both their business performance and liquidity and we wanted to ensure that we are addressing both. I remain confident in Aurora's prospects and it is my utmost priority to secure our winning future."

 

Canopy Growth Corporation (TSX: WEED) (NYSE: CGCtoday announced its financial results for the second quarter fiscal 2021 ended September 30, 2020.  All financial information in this press release is reported in millions of Canadian dollars, unless otherwise indicated.

"Our renewed strategy of winning consumer mindshare, along with increased agility and execution, has resulted in record net revenue for the second quarter and momentum across key areas of business," said David Klein, CEO.  "Canopy Growth is positioned for continued growth as we establish a strong leadership position that is showcased through our vast portfolio of differentiated brands and products – including our industry leading cannabis-infused beverages."

 

"We saw another quarter of improvement in our operating expense ratio while our marketing and R&D investments are being re-directed to drive sales," added Mike Lee, CFO. "Importantly, our end-to-end review has identified cost savings opportunities in the range of $150-$200 million across cost of goods sold, general and administrative expenses, and inventory, and efforts are underway to quickly capture value.  Leveraging ongoing improvements across our business, we are accelerating our path to profitability, notably in our largest market, Canada."

 

Canopy Rivers Inc. (TSX: RIV) (OTC:CNPOFtoday released its unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three and six months ended September 30, 2020.

 

"Our quarter was framed with a sharp focus on PharmHouse. We provided debtor-in-possession financing to enable PharmHouse to remain operational as it commenced its CCAA process and our team has been working towards securing the best possible outcome for our shareholders," said Narbe Alexandrian, President and CEO, Canopy Rivers. "While supporting PharmHouse has been our priority, we are confident we will put this challenging situation behind us and remain encouraged by the progress across our portfolio. This quarter, we participated in Headset's bridge round as it continues to bring its industry-leading analytical tools to new markets, High Beauty launched a new product line, and BioLumic's most recent cannabis field trials showed promising gains in dried flower mass and cannabinoid content."

 

"Most notably, the value of TerrAscend's common shares increased by 101% during the quarter, and the implied value of our investment in TerrAscend is now approximately $214 million," added Alexandrian. "After a U.S. election that potentially spells good outcomes for the cannabis sector, including the legalization of adult-use cannabis in New Jersey, we are pleased to have our U.S. exposure through our holdings of exchangeable shares in one of the nation's leading multistate operators. We believe that we will be well positioned to capitalize on opportunities in the U.S. once we are permitted to do so."

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#COVID19 Second Wave? From #Sanitizers to #PPE’s, Companies are Preparing (OTC: $HIPH) (OTC: $OPTI) (OTC: $ATWT) (OTC: $RLLVF) @AmericanPremium @optecfuelintl @AtwecTech @RELEVIUMCORP

#COVID19 Second Wave? From #Sanitizers to #PPE’s, Companies are Preparing (OTC: $HIPH) (OTC: $OPTI) (OTC: $ATWT) (OTC: $RLLVF) @AmericanPremium @optecfuelintl @AtwecTech @RELEVIUMCORP

 


Point Roberts WA, Delta, BC – November 9, 2020 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a special report on the continued growth of the sanitation and PPE sectors as businesses around the world look to supply the new COVID reality and prepare for a potential second wave.

 

Read this news, featuring HIPH in full at https://www.investorideas.com/news/2020/main/11091COVID-19-Second-Wave.asp

 

While COVID-19 has impacted many businesses both negatively and positively, as we enter into the colder seasons many companies are using this time to bring new sanitation and PPE products to market in anticipation of another rise in demand as well as to help prevent further spread of the pandemic.

 

American Premium Water Corporation (OTC: HIPHrecently announced that it has begun production on the first run of proprietary nano-infused products through its distribution agreement with BioHealth Water Inc., a wholly owned subsidiary of Alset International Limited (SGX:40V). The initial production run marks the beginning of the Company’s efforts to sell its aerosolized sanitizing machines in addition to its two new products utilizing its proprietary Hydro Nano technology: Nano Energy Water and Nitrous Oxide Shots. The products are in the process of applications for product distribution in Malaysia, Hong Kong, Taiwan, Singapore, USA and Canada.

 

Ryan Fishoff, CEO of American Premium Water commented, “I am excited to announce the beginning of production for our new products with our new partner in BioHealth Water. This first run will get the products into the hands of distributors across the Pacific Rim (North America & Asia). We are only scratching the surface of the potential that we have with BioHealth Water and I look forward to receiving feedback from our distributors as we prepare for full scale production later this year. Our plans to increase the volume of distribution alongside various other initiatives that we intend to achieve in the remaining quarter of 2020 will set a firm platform for us to move full steam into 2021. As I have been emphasizing over the years, I believe this partnership highlights the value of the Company’s Hydro Nano technology. We are exploring even more ways to unlock value from this technology, and I look forward to sharing these developments with shareholders in the coming weeks and months.”

 

The Company previously announced in April that it had developed a prototype of an aerosolized sanitizing machine using its proprietary Hydro Nano technology. This production run will be the first run of the devices and its accompanying sanitizing nano-solution. All products will be sold through HWH global distributors (www.hwhworld.com) and direct sales in the respective countries.

 

Chan Heng Fai, Chairman and CEO of Alset commented, “I am very excited to begin selling these products across our global distribution channels. All three products have the potential to make an extraordinary impact that I believe will translate well to the consumer and drive sales. I see a tremendous opportunity with the sanitizing machine to assist small businesses that are looking for an effective solution to bring customers back through the door. I am also looking forward to bringing Nano Energy Water to market, which I believe will make a big impact with customers. I look forward to working with Ryan and his team to continue growing distribution and bring even more impactful products to market in the coming years.”

 

OPTEC International, Inc (OTC:OPTI) announced recently that it has successfully secured a fully executed definitive agreement for the supply of Brand Specific Personal Protection Equipment (PPE) products for a large International Commodities Consortium totaling in excess of $2 Billion Dollars US.

 

OPTEC CEO, Roger Pawson commented "The company has been working for over a month to bring the transaction to successful closing and we are extremely happy to announce the execution of the definitive agreement and preparation of the massive logistics operation for the distribution of the products, furthermore OPTEC has entered into an additional agreement with an established Freight and Logistics organization for the transportation of products to the final destinations in the Healthcare, Medical, and Hospital sectors.

 

Item 1.01 Entry into A Material Definitive Agreement.

  1. If the registrant has entered into a material definitive agreement not made in the ordinary course of business of the registrant, or into any amendment of such agreement that is material to the registrant, disclose the following information:

 

On October 30, 2020 the Company (OPTEC) entered into a definitive agreement with a large International Commodities Consortium for the supply and distribution of Specific Brands of Personal Protection Equipment (PPE) for Medical & Hospital use throughout North America, totaling in excess of Two Billion Dollars $US. The agreement has been fully executed by the company and the buyer, along with proofed bank certified funds to complete the transaction in excess of $2 Billion Dollars US. The company (OPTEC) has already sourced and secured the products for the entire agreement, along with coordinating the logistics portion of the agreement. The product distribution is expected to be fully completed by December 2020.

 

Another company based in health and wellness like American Premium Water, Relevium Technologies Inc. (TSX.V: RLV) (OTC: RLLVF), announced in September that its wholly-owned subsidiary in the US, BGX E-Health LLC, had secured up to eight chartered flights to deliver USD$16.9 Million of critical PPE to the Canadian Health Care Market, which arrived over the next 7-10 days in Canada.

 

On September 17, 2020, the Company announced it had secured an initial contract totaling USD$20 million of critical PPE aimed for the Canadian healthcare market. The Company is now focused on the delivery of this initial contract, as we all, on pursuing new opportunities in the space.

 

This initial delivery represented approximately 75% of the initial previously announced contract.

 

BGX E-Health, the Company’s US wellness subsidiary has pivoted into the Emergency Segment of the Health and Wellness market by launching its own line of hand sanitizers and developing air purifier solutions. In the early summer months of this year, the Company identified an opportunity to make a difference in the supply of critical PPE and on July 13, 2020 the company announced a joint venture between Relevium and H-Source to join forces to bring critical PPE to the areas in need in a secure and traceable platform.

 

Aurelio Useche, CEO of Relevium stated, “Our team has been on site in the US sourcing both, local and overseas supplies of critical PPE and we are pleased to announce the scheduling of several airfreight charts to deliver the urgently products on a timely basis. We now set our sights on further development of this space as we expand our customer base in conjunction with our partners.”

 

This industry is attracting attention from businesses from all sectors. Even child safety and security company, ATWEC Technologies (OTC: ATWTannounced that it is giving transportation companies and passengers yet another layer of protection. The company has introduced the KV-X Sterilization System, a new automated, two-stage sterilization system for school buses, daycare vans, and other commercial vehicles that kills germs, viruses, and bacteria in the air and on vehicle surfaces quickly, safely and effectively.

 

Built for 15-passenger vehicles or larger, the KV-X features a 30-minute, two-stage sanitization module that adheres to all FDA guidelines. When the KV-X system is initiated, a built-in induction fan draws air through an easily replaceable HEPA filter and into a self-contained ultraviolet light (UVC) to disinfect the air within the vehicle. During the next stage, ozone is generated to clean seats, door handles, and other high-touch internal surfaces. UVC and ozone have been scientifically tested and used for years to kill airborne and surface germs and viruses.

 

The KV-X comes with a built-in timer, enabling users to schedule the system to self-start at a pre-designated time, typically overnight, to ensure vehicles are properly sanitized for next-day use. An always-on motion sensor (the same technology that powers ATWEC's KV-4 Child Reminder System) confirms a vehicle is empty before the KV-X sterilization cycle can begin. If the KV-X detects motion during the cycle, it will immediately shut down the system to prevent direct passenger exposure to the ozone and UVC.

 

"When it comes to transportation, our mission is to ensure the safest ride for each child, passenger and driver. In today's environment, expanding our product line into vehicle sanitization was obvious," said Darnell Stitts, President and CEO at ATWEC Technologies. "The KV-X Sterilization System is a safe, fast, and efficient way for school systems, daycare organizations, commercial transportation services, and even public transportation agencies to give passengers and their families peace of mind and a cleaner, healthier riding experience."

 

The KV-X can be installed in any 15-passenger vehicle or larger. It is more efficient than traditional manual aerosol mist applications and it does not rely on a vehicle's air conditioning system to operate. This process allows the vehicle to be sanitized quickly and be back into operation sooner.

 

As governments around the world struggle to provide adequate sanitation and PPE equipment to hospitals and essential workers, the public sector continues to capitalize on this market growth opportunity and through new innovations is helping to ensure that customers have access to adequate sanitation and PPE equipment in a post COVID world.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com –More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

 

 

 

 

 



 

 

Friday, November 6, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 492 (CSE: $FTRP.C) (CSE: $CURA.C) (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $HEMP)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 492 (CSE: $FTRP.C) (CSE: $CURA.C) (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $HEMP)

 


Delta, Kelowna, BC, November 6, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/110620-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/11061FTRP-CURA-WEED-CGC-HEMP.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public announcements and these relate to current market trends created from new state legalization.

 

Field Trip Health Ltd. (CSE: FTRP), one of the leaders in the development and delivery of psychedelic therapies, announced today that it is in advanced stages of identifying potential sites for Field Trip Health centers to treat people in Oregon with psilocybin therapies following the passage of Measure 109.

 

Measure 109, which was approved by voters in Oregon on November 3, 2020, requires the Oregon Health Authority to create a licensing system that will create a regulated program for the cultivation of psilocybin-producing mushrooms and the provision of supervised psilocybin therapy, effectively creating the first legal market for psilocybin therapies in North America.

Field Trip, which has been cultivating twenty-five species and strains of psilocybin-producing mushrooms at its research facility at the University of West Indies (Mona) in Jamaica since January, also announced its intention to seek licenses for cultivation in the State of Oregon when regulations following from Measure 109 are established.

“Based on its geography and climate, Oregon is an ideal place for cultivation of psilocybin-producing mushrooms. But cultivation that meets all quality standards and analytical testing requirements is complex,” said Marshall Tyler, Field Trip’s Director of Research. “Our current cultivation research, which is focused on developing safety methods for microbial contamination, pesticides, mycotoxins, heavy metals, and analyzing tryptamine content from all psychoactive species at all stages of growth, positions us well to establish effective cultivation operations in Oregon and, subject to the regulations that are established, to be able to offer a wide variety of products and therapies to the people in Oregon.”

 

Studies from institutions such as Johns Hopkins University, New York University and Imperial College London have demonstrated that psilocybin therapy, when performed by qualified professionals, can have profoundly positive effects on treating mental and emotional health challenges such as depression, anxiety, end of life distress and addiction. Similar studies have demonstrated that psychedelic therapies may also increase a person’s creativity, empathy, openness to others viewpoints and regard for the environment and planet.

 

“From the earliest days at Field Trip, we built our business case on the belief that the psychedelic industry would develop on two parallel and complementary paths: one that would be purely medical for the treatment of diagnosed mental health conditions, and the other which would make psychedelic therapies available to a wider audience,” said Ronan Levy, Executive Chairman of Field Trip Health Ltd. “The success of Measure 109 validates that belief, and positions us to be the clear leader in the emerging psychedelics industry. With Field Trip Health centers rolling out across North America delivering best-in-class psychedelic therapies, and our research on cultivation of psilocybe, we are extremely well-positioned to help Oregonians access best-in-class psilocybin therapies. And with our drug development work on FT-104, our novel psychedelic molecule, advancing ahead of schedule, we are also positioned to help extend the psychedelic renaissance to people around the world."

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced a pair of planned asset divestitures in Maryland for a combined $31.5 million in total proceeds:

       Entering into Definitive documentation to sell Curaleaf's interests in HMS cultivation and processor for $27.5 million to TerrAscend Corp. ("TerrAscend") (CSE:TER, OTCQX: TRSSF)

       Closing of its sale of Cumberland, MD processor for $4.0 million

 

Curaleaf announced today the signing of a definitive agreement to sell its rights to the HMS Health LLC and HMS Processing LLC ("HMS") assets in Maryland to TerrAscend for a total consideration of $27.5 million. The HMS asset sale includes the divestiture of operations in a 22,000 square foot co-located cultivation and processing facility in Frederick, MD. The total consideration due to Curaleaf of $27.5 million includes $25 million in cash due at closing as well as a $2.5 million interest bearing Note due and payable to Curaleaf on April 30, 2022. The transaction is expected to close pending customary closing conditions, including regulatory approval by the Maryland Medical Cannabis Commission.

 

The completion of the HMS transaction will allow Curaleaf to move forward, subject to regulatory approval, with its proposed acquisition of Maryland Compassionate Care and Wellness, LLC ("MCCW"), which operates a 55,000 square foot co-located cultivation and processing facility in Taneytown, MD and a dispensary in Gaithersburg, MD under the Herbology brand.

 

Curaleaf also announced today the closing of its sale of Curaleaf Maryland, Inc., which holds a processing license in Cumberland, MD, for a total consideration of $4.0 million. This divestiture closed on November 1, 2020 and supports Curaleaf's strategy for optimizing its vertically integrated presence in Maryland.

 

Joseph Lusardi, Chief Executive Officer of Curaleaf, stated, "The asset sales we announce today will allow us to optimize Curaleaf's vertically integrated presence in Maryland within the regulation which limits operators to a single grow and single processor. Overall, the Maryland market continues to see impressive growth with over 115,000 certified cannabis patients. The actions we are taking aim to further strengthen Curaleaf's position as a leading cannabis operator in Maryland as well as reaffirm our commitment to best serving our customers across the state."

 

Canopy Growth Corporation (TSX:WEED) (NYSE:CGC), a world-leading diversified cannabis, hemp, and cannabis device company, announced the launch of Quatreau, a new line of premium CBD-infused beverages. The naturally flavoured sparkling waters are Canopy Growth's first CBD-infused drinks, with both CBD-only and "balanced" (CBD + THC) offerings available in Canada. Launched on the heels of incredible growth in sales from the Company's THC-infused beverages, released earlier this year, Canopy Growth is uniquely positioned to win market share in the CBD beverage space.

 

"We are proud to debut our first CBD-infused beverage brand in Canada, where we already lead the cannabis-infused beverage category, at a price point that delivers both quality and value to consumers," said David Klein, CEO, Canopy Growth.  "We created Quatreau as an alternative to sugary, caffeinated beverages or even alcohol. With both CBD-only and "balanced" (CBD + THC) offerings in four natural flavours, Quatreau meets the needs of discerning cannabis consumers."

 

Canopy Growth plans to continue developing category leading brands that are driven by consumer insights, product-focused, with industry leading scientific formulation. Building on the successful launch and strong sales of THC-infused cannabis beverage brands Tweed, Houseplant and Deep Space, Canopy is poised to continue leading the cannabis space with the launch of Quatreau CBD-infused sparkling water, a consistent CBD product in a beverage format that is familiar to consumers.

 

Quatreau's naturally flavoured Canadian product line includes four offerings named:

       Quatreau Cucumber + Mint (contains 20 mg of CBD and < 1 mg of THC)

       Quatreau Passion Fruit + Guava (contains 20 mg of CBD and < 1 mg of THC)

       Quatreau Ginger + Lime (contains 2 mg of CBD and 2 mg of THC)

       Quatreau Blueberry + Açai (contains 2 mg of CBD and 2 mg of THC)

 

Canopy was also among this week’s large LP winners when it came to the markets, trading up nearly 5% over the past three days and joining other winners such as Aurora Cannabis (TSX: ACB) (NYSE: ACB), which traded up nearly 70% over the past three days, Aphria Inc. (NASDAQ: APHA) (TSX: APHA), trading up 5% and Tilray Inc. (NASDAQ: TLRY) which traded up nearly 30%.

 

 

Hemp, Inc. (OTC: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, announced praise of five states that will now legalize marijuana for recreational and/or medical use.

 

Bruce Perlowin, CEO of Hemp, Inc., 55-year veteran of the marijuana industry, now known as the King of Hemp says, “Marijuana is coming full circle, but legally now.  Back in my heyday, I was (and still) widely known as the King of Pot so it’s interesting to see how things have progressed over the years and exciting to see where we’ll be in the future.”

 

“Hemp, Inc. is planning to launch a new division, Medical and Recreational Marijuana,” says Perlowin.  Thus far, there are no firm plans on what direction the Company will take in this new planned division since the opportunities are so vast.  According to Perlowin, he will evaluate all the lucrative, potential opportunities and make a decision on how the company will enter the cannabis market in 2021.

 

“We may wait until full federal legalization. Once marijuana is fully legalized across the country, I think banks and merchant account providers will be more open and accepting of marijuana companies. Right now, the banking regulations for marijuana companies are very draconian. I’ve known so many banks to close accounts merely because they were associated with the industry. Anyway, we don’t know if we’ll wait for full legalization yet but that decision won’t discount the building out of facilities and preparation for it.  After legalization occurs and large scale marijuana grows are underway, we would already be positioned as a ‘go-to’ consultant due to our industry expertise.”

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


 

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory